Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

TD Cowen analyst Charles Rhyee maintained a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $250.00. The ...

Animal rescuers have helped save pets affected by devastating wildfires in Southern California by flying more than 80 cats and dogs to a no-kill shelter in Utah. The flight carried 26 dogs and 58 ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Cencora (COR) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Cencora COR has outperformed the market over the past 10 years by 6.19% on an annualized basis producing an average annual return of 17.58%. Currently, Cencora has a market capitalization of $49. ...

Wells Fargo analyst Stephen Baxter maintained a Hold rating on Cencora (COR – Research Report) yesterday and set a price target of $251.00. The ...

Cencora, Inc. (NYSE:COR – Get Free Report)’s share price reached a new 52-week high on Monday after JPMorgan Chase & Co. raised their price target on the stock from $289.00 to $301.00.

Harrow's "Harrow Cares" program, in partnership with Cencora, aims to improve access and affordability of eye care treatments for retina specialists and patients. The program includes a patient ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...